{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:36:31Z","timestamp":1787319391668,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Operational Infrastructure Support Grant"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2018.03.015","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T08:31:19Z","timestamp":1523867479000},"page":"2158-2165","source":"Crossref","is-referenced-by-count":32,"title":["NXY-059, a Failed Stroke Neuroprotectant, Offers No Protection to Stem Cell-Derived Human Neurons"],"prefix":"10.1016","volume":"27","author":[{"given":"Ana","family":"Antonic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Dottori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm R.","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey A.","family":"Donnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Howells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0010","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1474-4422(07)70031-5","article-title":"Preventing stroke: saving lives around the world","volume":"6","author":"Strong","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1747-4949.2012.00805.x","article-title":"Improving the efficiency of the development of drugs for stroke","volume":"7","author":"Howells","year":"2012","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0020","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrneurol.2011.89","article-title":"How to make better use of thrombolytic therapy in acute ischemic stroke","volume":"7","author":"Donnan","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0025","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","article-title":"Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials","volume":"375","author":"Lees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0030","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa1109842","article-title":"A randomized trial of tenecteplase versus alteplase for acute ischemic stroke","volume":"366","author":"Parsons","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0035","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion-imaging selection","volume":"372","author":"Campbell","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0040","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1016\/j.bmcl.2005.04.043","article-title":"Nitrone derivatives of trolox as neuroprotective agents","volume":"15","author":"Balogh","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0045","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00004647-199907000-00008","article-title":"Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat","volume":"19","author":"Kuroda","year":"1999","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0050","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1161\/01.STR.0000017145.22806.AA","article-title":"Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator","volume":"33","author":"Lapchak","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0055","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/01.STR.0000015346.00054.8B","article-title":"Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator","volume":"33","author":"Lapchak","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2004.02.005","article-title":"Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores","volume":"188","author":"Lapchak","year":"2004","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0065","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/01.STR.0000087790.79851.A8","article-title":"Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion","volume":"34","author":"Marshall","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0070","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1161\/01.STR.32.1.190","article-title":"NXY-059, a free radical\u2013trapping agent, substantially lessens the functional disability resulting from cerebral ischemia in a primate species","volume":"32","author":"Marshall","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0075","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.bjp.0704449","article-title":"Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window","volume":"135","author":"Sydserff","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-8993(02)02922-0","article-title":"NXY-059 maintains Akt activation and inhibits release of cytochrome C after focal cerebral ischemia","volume":"947","author":"Yoshimoto","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0006-8993(02)02286-2","article-title":"Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A","volume":"932","author":"Yoshimoto","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0006-8993(01)02618-X","article-title":"NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat","volume":"909","author":"Zhao","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0095","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/jscd.2002.123973","article-title":"Pharmacokinetics of NXY-059, a nitrone-based free radical trapping agent, in healthy young and elderly subjects","volume":"11","author":"Edenius","year":"2002","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00228-002-0478-x","article-title":"Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke","volume":"58","author":"Strid","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/01.STR.32.3.675","article-title":"Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke","volume":"32","author":"Lees","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0110","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa052980","article-title":"NXY-059 for acute ischemic stroke","volume":"354","author":"Lees","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMoa070240","article-title":"NXY-059 for the treatment of acute ischemic stroke","volume":"357","author":"Shuaib","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0120","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/STROKEAHA.107.503334","article-title":"NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials","volume":"39","author":"Diener","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0125","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1161\/STROKEAHA.106.479170","article-title":"Life after cerovive: a personal perspective on ischemic neuroprotection in the post-NXY-059 era","volume":"38","author":"Ginsberg","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ana.21210","article-title":"Neuroprotection in the SAINT-II aftermath","volume":"62","author":"Hermann","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.expneurol.2007.03.003","article-title":"A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke","volume":"205","author":"Savitz","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0140","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ana.21127","article-title":"Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials","volume":"61","author":"Savitz","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0145","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1161\/STROKEAHA.107.489161","article-title":"SAINT-I worked, but the neuroprotectant is not NXY- 059","volume":"38","author":"Proctor","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0150","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1161\/STROKEAHA.108.515957","article-title":"Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality","volume":"39","author":"Macleod","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0155","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1476-5381.2009.00196.x","article-title":"Effects of NXY-059 in experimental stroke: an individual animal meta-analysis","volume":"157","author":"Bath","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0160","doi-asserted-by":"crossref","first-page":"10461","DOI":"10.1073\/pnas.0600930103","article-title":"Cardiac glycosides provide neuroprotection against ischemic stroke: discovery by a brain slice-based compound screening platform","volume":"103","author":"Wang","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.jcbfm.9600517","article-title":"The nitrone disodium 2,4-sulphophenyl-N- tert-butylnitrone is without cytoprotective effect on sodium nitroprusside-induced cell death in N1E-115 neuroblastoma cells in vitro","volume":"28","author":"Hainsworth","year":"2008","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0170","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2009.07.035","article-title":"Cerebrovascular protection as a possible mechanism for the protective effects of NXY-059 in preclinical models: an in vitro study","volume":"1294","author":"Culot","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0175","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(02)03469-8","article-title":"In vitro blood- brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions","volume":"955","author":"Dehouck","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0180","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/ijs.12224","article-title":"Hypothermia protects human neurons","volume":"9","author":"Antonic","year":"2014","journal-title":"Int J Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0185","series-title":"Protocols for Neural Cell Culture","first-page":"75","article-title":"Neural differentiation of human embryonic stem cells","author":"Dottori","year":"2010"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0190","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ana.20741","article-title":"1,026 experimental treatments in acute stroke","volume":"59","author":"O'Collins","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0195","first-page":"58","article-title":"The beneficial failure of the FAST-MAG trial. Prehospital magnesium didn't help stroke patients, but we still learned a lot","volume":"43","author":"Hatez","year":"2014","journal-title":"EMS World"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0200","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/jcbfm.2010.184","article-title":"Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing","volume":"31","author":"O'Collins","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0205","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/480161a","article-title":"Novartis to shut brain research facility","volume":"480","author":"Abbott","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jstrokecerebrovasdis.2018.03.015_bib0210","article-title":"R&D cuts curb brain-drug pipeline","author":"Stovall","year":"2011","journal-title":"Wall St J"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718301563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305718301563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T12:11:00Z","timestamp":1530706260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305718301563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S1052305718301563"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2018.03.015","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}